PlumX Metrics
Embed PlumX Metrics

Assessment of prognostic factors in pediatric adrenocortical tumors: The modified pediatric S-GRAS score in an international multicenter cohort - A work from the ENSAT-PACT working group

European Journal of Endocrinology, ISSN: 1479-683X, Vol: 191, Issue: 1, Page: 64-74
2024
  • 0
    Citations
  • 0
    Usage
  • 2
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Captures
    2
  • Mentions
    1
    • News Mentions
      1
      • News
        1

Most Recent News

All India Institute of Medical Sciences (AIIMS) Reports Findings in Endocrinology (Assessment of prognostic factors in pediatric adrenocortical tumors: The modified pediatric S-GRAS score in an international multicenter cohort: A work from the ...)

2024 JUL 05 (NewsRx) -- By a News Reporter-Staff News Editor at Daily India Report -- New research on Health and Medicine - Endocrinology is

Article Description

Objective: Pediatric adrenocortical carcinoma (pACC) is rare, and prognostic stratification remains challenging. We aimed to confirm the prognostic value of the previously published pediatric scoring system (pS-GRAS) in an international multicenter cohort. Design: Analysis of pS-GRAS items of pACC from 6 countries in collaboration of ENSAT-PACT, GPOH-MET, and IC-PACT. Methods: We received patient data of the pS-GRAS items including survival information from 9 centers. PS-GRAS score was calculated as a sum of tumor stage (1 = 0; 2-3 = 1; 4 = 2 points), grade (Ki67 index: 0%-9% = 0; 10%-19% = 1; ≥20% = 2 points), resection status (R0 = 0; RX/R1/R2 = 1 point), age (<4 years = 0; ≥4 years = 1 point), and hormone production (androgen production = 0; glucocorticoid-/mixed-/no-hormone production = 1 point) generating 8 scores and 4 groups (1: 0-2, 2: 3-4, 3: 5, 4: 6-7). Primary endpoint was overall survival (OS). Results: We included 268 patients with median age of 4 years. The analysis of the pS-GRAS score showed a significantly favorable prognosis in patients with a lower scoring compared to higher scoring groups (5-year OS: Group 1 98%; group 2 87% [hazard ratio {HR} of death 3.6, 95% CI of HR 1.6-8.2]; group 3 43% [HR of death 2.8, 95% CI 1.9-4.4]; group 4: OS 18% [HR of death 2.1, 95% CI 1.7-2.7]). In the multivariable analysis, age (HR of death 3.5, 95% CI 1.8-7.0), resection status (HR of death 5.5, 95% CI 2.7-11.1), tumor stage (HR of death 1.9, 95% CI of HR 1.2-3.0), and Ki67 index (HR of death 1.7, 95% CI 1.2-2.4) remained strong independent outcome predictors. Especially infants < 4 years showed more often low-risk constellations with a better OS for all tumor stages. Conclusion: In an international multicenter study, we confirmed that the pS-GRAS score is strongly associated with overall survival among patients with pACC. Age, resection status, stage, and Ki67 index are important parameters for risk stratification.

Bibliographic Details

Riedmeier, Maria; Agarwal, Shipra; Antonini, Sonir; Costa, Tatiana E I Jaick B; Diclehan, Orhan; Fassnacht, Martin; Figueiredo, Bonald C; Guran, Tulay; Härtel, Christoph; Haubitz, Imme; Idkowiak, Jan; Kuhlen, Michaela; Noronha, Lúcia; Parise, Ivy Zortéa S; Redlich, Antje; Puglisi, Soraya; Saniye, Ekinci; Schlegel, Paul-Gerhardt; Yalcin, Bilgehan; Wiegering, Verena

Oxford University Press (OUP)

Medicine; Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know